US Stock MarketDetailed Quotes

IRMD IRadimed

Watchlist
  • 48.450
  • -0.180-0.37%
Close Sep 18 16:00 ET
  • 48.450
  • 0.0000.00%
Post 16:02 ET
613.85MMarket Cap33.18P/E (TTM)

IRadimed Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
11.15%17.93M
13.72%17.6M
23.00%65.56M
17.42%17.45M
23.10%16.5M
26.80%16.13M
25.70%15.48M
27.48%53.3M
25.19%14.86M
22.92%13.41M
Operating revenue
11.15%17.93M
13.72%17.6M
23.00%65.56M
17.42%17.45M
23.10%16.5M
26.80%16.13M
25.70%15.48M
27.48%53.3M
25.19%14.86M
22.92%13.41M
Cost of revenue
-0.62%3.92M
12.17%4.21M
28.15%15.4M
10.87%4.04M
28.02%3.67M
52.76%3.94M
28.06%3.75M
23.10%12.02M
38.89%3.64M
14.50%2.86M
Gross profit
14.96%14.01M
14.22%13.39M
21.50%50.16M
19.54%13.41M
21.77%12.84M
20.19%12.19M
24.97%11.72M
28.81%41.28M
21.30%11.22M
25.43%10.54M
Operating expense
16.05%8.38M
11.99%8.64M
17.42%30.12M
18.47%8.25M
8.14%6.93M
20.93%7.22M
22.36%7.71M
15.39%25.65M
13.46%6.97M
20.53%6.41M
Selling and administrative expenses
21.08%7.58M
12.97%7.82M
16.63%27.26M
19.51%7.6M
9.47%6.48M
17.91%6.26M
19.62%6.92M
15.00%23.38M
12.69%6.36M
22.34%5.92M
-Selling and marketing expense
17.91%3.48M
27.57%3.83M
-4.24%12.14M
-9.16%3.33M
-5.69%2.86M
1.40%2.95M
-2.27%3M
20.12%12.68M
17.43%3.67M
17.46%3.04M
-General and administrative expense
23.90%4.1M
1.80%3.99M
41.37%15.12M
58.47%4.27M
25.45%3.62M
37.88%3.31M
44.35%3.92M
9.47%10.7M
6.84%2.7M
27.94%2.88M
Research and development costs
-16.72%801.13K
3.44%821K
25.49%2.86M
7.56%650.44K
-7.95%452.56K
45.18%961.95K
52.90%793.72K
19.58%2.28M
22.21%604.74K
2.28%491.64K
Operating profit
13.38%5.63M
18.49%4.75M
28.21%20.04M
21.30%5.16M
42.91%5.91M
19.12%4.96M
30.32%4.01M
59.18%15.63M
36.80%4.25M
33.87%4.13M
Net non-operating interest income expense
220.38%1.86M
1,571.70%581.85K
Non-operating interest income
----
----
220.38%1.86M
----
----
----
----
1,571.70%581.85K
----
----
Other net income (expense)
91.49%642.22K
44.61%495.15K
-461.13%-161.32K
-915.98%-1.34M
378.40%503.19K
2,459.82%335.39K
2,395.74%342.41K
-77.45%-28.75K
-327.90%-132.12K
1,372.53%105.18K
Gain on sale of security
----
----
-417.75%-148.84K
----
----
----
----
-77.45%-28.75K
----
----
Special income (charges)
----
----
---12.47K
----
----
----
----
--0
----
----
-Gain on sale of property,plant,equipment
----
----
---12.47K
----
----
----
----
--0
----
----
Other non- operating income (expenses)
91.49%642.22K
44.61%495.15K
----
----
378.40%503.19K
2,459.82%335.39K
2,395.74%342.41K
----
----
1,372.53%105.18K
Income before tax
18.32%6.27M
20.55%5.24M
34.35%21.74M
20.79%5.68M
51.23%6.41M
26.77%5.3M
42.15%4.35M
64.50%16.18M
51.07%4.7M
36.96%4.24M
Income tax
22.30%1.37M
17.31%1.11M
35.59%4.55M
10.87%1.14M
65.52%1.34M
19.17%1.12M
64.59%943.59K
556.26%3.35M
232.19%1.03M
56.51%810.38K
Net income
17.26%4.9M
21.45%4.14M
34.02%17.19M
23.58%4.54M
47.86%5.07M
28.97%4.18M
36.97%3.41M
37.56%12.83M
-5.63%3.67M
33.03%3.43M
Net income continuous Operations
17.26%4.9M
21.45%4.14M
34.02%17.19M
23.58%4.54M
47.86%5.07M
28.97%4.18M
36.97%3.41M
37.56%12.83M
-5.63%3.67M
33.03%3.43M
Minority interest income
Net income attributable to the parent company
17.26%4.9M
21.45%4.14M
34.02%17.19M
23.58%4.54M
47.86%5.07M
28.97%4.18M
36.97%3.41M
37.56%12.83M
-5.63%3.67M
33.03%3.43M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
17.26%4.9M
21.45%4.14M
34.02%17.19M
23.58%4.54M
47.86%5.07M
28.97%4.18M
36.97%3.41M
37.56%12.83M
-5.63%3.67M
33.03%3.43M
Basic earnings per share
18.18%0.39
22.22%0.33
33.33%1.36
24.14%0.36
48.15%0.4
26.92%0.33
35.00%0.27
34.21%1.02
-6.45%0.29
28.57%0.27
Diluted earnings per share
15.15%0.38
18.52%0.32
32.35%1.35
24.14%0.36
48.15%0.4
26.92%0.33
35.00%0.27
37.84%1.02
-6.45%0.29
35.00%0.27
Dividend per share
0.15
0
0.15
0.15
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 11.15%17.93M13.72%17.6M23.00%65.56M17.42%17.45M23.10%16.5M26.80%16.13M25.70%15.48M27.48%53.3M25.19%14.86M22.92%13.41M
Operating revenue 11.15%17.93M13.72%17.6M23.00%65.56M17.42%17.45M23.10%16.5M26.80%16.13M25.70%15.48M27.48%53.3M25.19%14.86M22.92%13.41M
Cost of revenue -0.62%3.92M12.17%4.21M28.15%15.4M10.87%4.04M28.02%3.67M52.76%3.94M28.06%3.75M23.10%12.02M38.89%3.64M14.50%2.86M
Gross profit 14.96%14.01M14.22%13.39M21.50%50.16M19.54%13.41M21.77%12.84M20.19%12.19M24.97%11.72M28.81%41.28M21.30%11.22M25.43%10.54M
Operating expense 16.05%8.38M11.99%8.64M17.42%30.12M18.47%8.25M8.14%6.93M20.93%7.22M22.36%7.71M15.39%25.65M13.46%6.97M20.53%6.41M
Selling and administrative expenses 21.08%7.58M12.97%7.82M16.63%27.26M19.51%7.6M9.47%6.48M17.91%6.26M19.62%6.92M15.00%23.38M12.69%6.36M22.34%5.92M
-Selling and marketing expense 17.91%3.48M27.57%3.83M-4.24%12.14M-9.16%3.33M-5.69%2.86M1.40%2.95M-2.27%3M20.12%12.68M17.43%3.67M17.46%3.04M
-General and administrative expense 23.90%4.1M1.80%3.99M41.37%15.12M58.47%4.27M25.45%3.62M37.88%3.31M44.35%3.92M9.47%10.7M6.84%2.7M27.94%2.88M
Research and development costs -16.72%801.13K3.44%821K25.49%2.86M7.56%650.44K-7.95%452.56K45.18%961.95K52.90%793.72K19.58%2.28M22.21%604.74K2.28%491.64K
Operating profit 13.38%5.63M18.49%4.75M28.21%20.04M21.30%5.16M42.91%5.91M19.12%4.96M30.32%4.01M59.18%15.63M36.80%4.25M33.87%4.13M
Net non-operating interest income expense 220.38%1.86M1,571.70%581.85K
Non-operating interest income --------220.38%1.86M----------------1,571.70%581.85K--------
Other net income (expense) 91.49%642.22K44.61%495.15K-461.13%-161.32K-915.98%-1.34M378.40%503.19K2,459.82%335.39K2,395.74%342.41K-77.45%-28.75K-327.90%-132.12K1,372.53%105.18K
Gain on sale of security ---------417.75%-148.84K-----------------77.45%-28.75K--------
Special income (charges) -----------12.47K------------------0--------
-Gain on sale of property,plant,equipment -----------12.47K------------------0--------
Other non- operating income (expenses) 91.49%642.22K44.61%495.15K--------378.40%503.19K2,459.82%335.39K2,395.74%342.41K--------1,372.53%105.18K
Income before tax 18.32%6.27M20.55%5.24M34.35%21.74M20.79%5.68M51.23%6.41M26.77%5.3M42.15%4.35M64.50%16.18M51.07%4.7M36.96%4.24M
Income tax 22.30%1.37M17.31%1.11M35.59%4.55M10.87%1.14M65.52%1.34M19.17%1.12M64.59%943.59K556.26%3.35M232.19%1.03M56.51%810.38K
Net income 17.26%4.9M21.45%4.14M34.02%17.19M23.58%4.54M47.86%5.07M28.97%4.18M36.97%3.41M37.56%12.83M-5.63%3.67M33.03%3.43M
Net income continuous Operations 17.26%4.9M21.45%4.14M34.02%17.19M23.58%4.54M47.86%5.07M28.97%4.18M36.97%3.41M37.56%12.83M-5.63%3.67M33.03%3.43M
Minority interest income
Net income attributable to the parent company 17.26%4.9M21.45%4.14M34.02%17.19M23.58%4.54M47.86%5.07M28.97%4.18M36.97%3.41M37.56%12.83M-5.63%3.67M33.03%3.43M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 17.26%4.9M21.45%4.14M34.02%17.19M23.58%4.54M47.86%5.07M28.97%4.18M36.97%3.41M37.56%12.83M-5.63%3.67M33.03%3.43M
Basic earnings per share 18.18%0.3922.22%0.3333.33%1.3624.14%0.3648.15%0.426.92%0.3335.00%0.2734.21%1.02-6.45%0.2928.57%0.27
Diluted earnings per share 15.15%0.3818.52%0.3232.35%1.3524.14%0.3648.15%0.426.92%0.3335.00%0.2737.84%1.02-6.45%0.2935.00%0.27
Dividend per share 0.1500.150.15
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data